-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LQnTu4Qt40JQp15ZlHL2YhqopNo5mcEiDo/AstnIZIbTNAGRA8XRWZgLJ9EjWISR GtItfiUpZwh7fwPMT7V8gA== 0000950144-07-000951.txt : 20070208 0000950144-07-000951.hdr.sgml : 20070208 20070208144253 ACCESSION NUMBER: 0000950144-07-000951 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20070208 DATE AS OF CHANGE: 20070208 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BENTLEY PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000821616 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 591513162 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-40113 FILM NUMBER: 07592015 BUSINESS ADDRESS: STREET 1: BENTLEY PARK STREET 2: 2 HOLLAND WAY CITY: EXETER STATE: NH ZIP: 03833 BUSINESS PHONE: 6036586100 MAIL ADDRESS: STREET 1: BENTLEY PARK STREET 2: 2 HOLLAND WAY CITY: EXETER STATE: NH ZIP: 03833 FORMER COMPANY: FORMER CONFORMED NAME: BELMAC CORP /FL/ DATE OF NAME CHANGE: 19920703 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: MCGOVERN MICHAEL CENTRAL INDEX KEY: 0001031294 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: BUSINESS PHONE: 4048511928 MAIL ADDRESS: STREET 1: PO BOX 420528 CITY: ATLANTA STATE: GA ZIP: 30342 SC 13G/A 1 g05374sc13gza.htm BENTLEY PHARMACEUTICALS INC/MICHAEL MCGOVERN BENTLEY PHARMACEUTICALS INC/MICHAEL MCGOVERN
 

OMB APPROVAL
OMB Number: 3235-0145
Expires: February 28, 2009
Estimated average burden
hours per response...10.4


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G/A

Under the Securities Exchange Act of 1934
(Amendment No. 3)*

Bentley Pharmaceuticals, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

082657107

(Cusip Number)

December 31, 2006

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

        o Rule 13d-1 (b)

        þ Rule 13d-1 (c)

        o Rule 13d-1 (d)

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the notes).

 

 

             
13G
CUSIP No. 082657107
  1. Name of Reporting Person:
Michael McGovern		 I.R.S. Identification Nos. of above persons (entities only):
  2. Check the Appropriate Box if a Member of a Group:
    (a) o  
    (b) o  
  3. SEC Use Only:
  4. Citizenship or Place of Organization:
USA
Number of
Shares
Beneficially
Owned by
Each Reporting
Person With
5. Sole Voting Power:
3,184,428
6. Shared Voting Power:
None
7. Sole Dispositive Power:
3,184,428
8.Shared Dispositive Power:
None
  9.Aggregate Amount Beneficially Owned by Each Reporting Person:
3,284,428
  10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares:
o
  11.Percent of Class Represented by Amount in Row (9):
14.350%
  12.Type of Reporting Person:
IN

2

 

13G
       
Item 1.
  (a) Name of Issuer:
    Bentley Pharmaceuticals, Inc. (“Company”)
  (b) Address of Issuer's Principal Executive Offices:
    Bentley Park
2 Holland Way
Exeter, NH 03833
 
Item 2.
  (a) Name of Person Filing:
    Michael McGovern
  (b) Address of Principal Business Office or, if none, Residence:
    5910 Long Island Drive NW
Atlanta, GA 30328
  (c)Citizenship:
    USA
  (d) Title of Class of Securities:
    Common Stock
  (e) CUSIP Number:
    082657107
 
Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
  (a) o Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
  (b) o Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
  (c) o Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
  (d) o Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
  (e) o An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
  (f) o An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
  (g) o A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
  (h) o A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
  (i) o A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
  (j) o Group, in accordance with §240.13d-1(b)(1)(ii)(J).
 

3

 

13G
       
Item 4. Ownership.
  (a) Amount beneficially owned:
    3,284,428 shares
  (b) Percent of class:
    14.350%
  (c) Number of shares as to which the person has:
    (i) Sole power to vote or to direct the vote:
      3,184,428
    (ii) Shared power to vote or to direct the vote:
      None
    (iii) Sole power to dispose or to direct the disposition of:
      3,184,428
    (iv) Shared power to dispose or to direct the disposition of:
      None
 
Item 5.Ownership of Five Percent or Less of a Class.
 
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following o.
 
Item 6.Ownership of More than Five Percent on Behalf of Another Person.
 
Not applicable
 
Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.
 
Not applicable
 
Item 8.Identification and Classification of Members of the Group.
 
Not applicable
 
Item 9.Notice of Dissolution of Group.
 
Not applicable

4

 

13G
       
Item 10.Certification.
 
  (a)   The following certification shall be included if the statement is filed pursuant to Rule 13d-1(c):
 
      “By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having such purpose or effect.”

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
   
Date: February 8, 2007
   
By: /s/ Michael McGovern
Name: Michael McGovern


5 -----END PRIVACY-ENHANCED MESSAGE-----